Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine Dose Comparison in First Episode Psychosis
NCT00449397Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2003
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in psychosis, sponsored by AstraZeneca. Started Jul 2003; status: completed.
02
Drugs
quetiapine
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT00449397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449397.